Ki-67 Monoclonal Antibody (SolA15), eFluor™ 660 (50-5698-82)
Ki-67 Monoclonal Antibody (SolA15), FITC (11-5698-82)
41KZoWOxy4L._CLa|610,500|51nyEGz+Z-L.jpg,41TQKlArbkL.jpg|0,0,277,500+333,0,277,500+138,0,333,500_._SY200_.jpg
Pharmaceuticals | Free Full-Text | Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
PCT/2000/3 : PCT Gazette, Weekly Issue No. 3, 2000 - WIPO
Cancers | Free Full-Text | A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
Pharmaceuticals | Free Full-Text | Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
Ki-67 Monoclonal Antibody (SolA15), Alexa Fluor™ 700 (56-5698-82)
Meetings & Conferences of the AMS, Volume 50, Number 9
Anthropogeny Publications Exchange (APE) | Center for Academic Research and Training in Anthropogeny (CARTA)
Ki-67 Monoclonal Antibody (SolA15), Alexa Fluor™ 700 (56-5698-82)
Pharmaceuticals | Free Full-Text | Antibody–Drug Conjugates: The Last Decade
Ki-67 Monoclonal Antibody (SolA15), FITC (11-5698-82)
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines - ecancer
Pharmaceuticals | Free Full-Text | Antibody–Drug Conjugates: The Last Decade
The Epic Decline of Fighting in the NHL - NHL to SEATTLE
Biomedicines | Free Full-Text | Antibody–Drug Conjugates for Cancer Therapy | HTML
Cancers | Free Full-Text | A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
Untitled
Ki-67 Monoclonal Antibody (SolA15), Alexa Fluor™ 700 (56-5698-82)
CARTA-inspired Publications | Center for Academic Research and Training in Anthropogeny (CARTA)
Pharmaceuticals | Free Full-Text | Antibody–Drug Conjugates: The Last Decade
Cancers | Free Full-Text | A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
